Engel Group revenue falls 6 percent in 2025-2026 financial year
Engel Group announced it had closed the 2025-2026 financial year with about $1.64 billion in revenue, down 6 percent from the previous year.
The manufacturer of injection molding and automation technologies said in a press release it has secured several major customer projects in the U.S. involving “technologically advanced applications, underlining the region’s position as the Group’s most significant addressable market.”
While the U.S. market showed some increased momentum and Asia, especially southeast Asia and India, is growing, market conditions in Europe remained challenging, the company said.
Engel’s technical injection molding segment performed well, with orders from sectors including logistics and aerospace. The medical segment was strong but packaging “developed more cautiously,” the company said.
“The challenges persist in what remains a highly volatile global environment,” said Stefan Engleder, CEO of the Engel Group. “We remain firmly committed to strengthening our global footprint and our high-performance sales and service organization, enabling us to support our customers worldwide and create tangible added value for their success. Against this backdrop, Engel is advancing its internal transformation program as planned, with the clear objective of further securing its long-term competitiveness.”
Engel said its international production plants along with its Austrian sites are designed to meet evolving customer requirements. The Changzhou plant in China produced more than 1,000 injection molding machines in the 2025-2026 financial year, with approximately 700 more manufactured in Shanghai and Korea.
The company is emphasizing a dual-brand strategy, with Engel machines focused on customized solutions and Wintec, its cost-effective, all-electric line, aimed at standard applications. The Wintec line began its global rollout in April.
Engel Group is headquartered in Schwertberg, Austria; Engel Americas is based in York, Pa.